AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Owned and Leased Facilities Worldwide by Year
Owned and Leased Facilities Worldwide (facilities)
AbbVie Owned and Leased Facilities Worldwide: 600 in FY2025, down 0.3% from a year earlier.
Latest, FY2025
600
Period ended Dec 31, 2025
Change on a year earlier
-0.3%
602 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
“As of December 31, 2025, AbbVie owns or leases approximately 600 facilities worldwide, containing an aggregate of approximately 19.4 million square feet of floor space”
Source: Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗
Reported in Form 10-K Item 2 Properties.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Owned and Leased Facilities Worldwide (facilities) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 600 | -0.3% | Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 602 | -2.9% | Form 10-K (abbv-20241231.htm, filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 620 | -2.7% | Form 10-K (abbv-20231231.htm, filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 637 | -1.2% | Form 10-K (abbv-20221231.htm, filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 645 | – | Form 10-K (abbv-20211231.htm, filed 2022-02-18) ↗ |
Cite this data
StockData. (2026). AbbVie Owned and Leased Facilities Worldwide, annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/ops-facilities-cnt
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.